China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the effectiveness and safety of mepolizumab in severe CRSwNP in real-world clinical practice'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136491
Registration Time: 2026/11/11
Type: Observational study
Primary Sponsor: Meishan City Peoples Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=352511
Published by HT Digital Content Services with permission from Health Daily Digest....